Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Early RA patients on infilixim...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Early RA patients on infiliximab therapy show significant changes in sonographic measures of joint vascularity and serum VEGF by 18 weeks.
Bibliographic Details
Main Authors:
Taylor, P
,
Steuer, A
,
Charles, P
,
Gruber, J
,
Cosgrove, DO
,
Blomley, M
,
Wagner, C
,
Marsters, P
,
DeWoody, K
,
Maini, R
Format:
Journal article
Published:
2001
Holdings
Description
Similar Items
Staff View
Similar Items
SIGNIFICANT CHANGES IN SONOGRAPHIC MEASURES OF JOINT VASCULARITY AND SERUM VEGF IN EARLY RA PATIENTS ON INFLIXIMAB BY 18 WEEKS OF THERAPY
by: Taylor, P, et al.
Published: (2002)
Ultrasonographic evidence of attenuated joint destruction within 18 weeks in early RA patients treated with infliximab.
by: Taylor, P, et al.
Published: (2003)
JOINT DESTRUCTION IS ATTENUATED BY INFLIXIMAB IN EARLY RA PATIENTS WITH ULTRASONOGRAPHIC MARKERS OF POOR PROGNOSIS
by: Taylor, P, et al.
Published: (2003)
Infliximab attenuates joint destruction in early RA patients with ultrasonographic markers of poor prognosis.
by: Taylor, P, et al.
Published: (2002)
Ultrasonographic and radiographic evidence of attenuated joint destruction in early RA patients treated with infliximab
by: Taylor, P, et al.
Published: (2003)